comparemela.com

Latest Breaking News On - நோய்கள் மற்றும் நிபந்தனைகள் - Page 9 : comparemela.com

Fiel Becomes World s Most Streamed Latin Hit on Spotify

Press release content from News Direct Corporation. The AP news staff was not involved in its creation. ‘Fiel’ Becomes World’s Most Streamed Latin Hit on Spotify April 15, 2021 GMT News Direct While the pandemic derailed touring plans, Walter Kolm, CEO of the artist management firm WK Entertainment a roster highlighted by Carlos Vives, and cross-over sensation Maluma, Wisin and CNCO, made a bold pandemic pivot that led to the launch of WK Records. Today, WK Entertainment is celebrating ” Fiel,” the clingy reggaetón hit by Wisin, Jhay Cortez, and Los Legendarios, currently one of the most-streamed Latin songs in the world on Spotify’s Global Top 200 chart the list’s only Spanish language hit to crack the Top 10.

Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress Affimed N.V.April 15, 2021 GMT AFM13 monotherapy: Reported positive data from the preplanned interim analysis for the registration-directed trial in PTCL AFM13 combination with NK cells: Announced 100% objective response rate in four response evaluable patients, including 2 complete responses AFM24 monotherapy: AFM24 (phase 1/2a study) completed cohort 4 and is enrolling and treating patients in cohort 5; expansion cohorts expected to start in the second half of 2021 AFM24 combination with NK cells: IND application cleared by the FDA for the combination of AFM24 with NKGen Biotech’s SNK-01 NK autologous cell therapy

Reata Announces the Appointments of Christy J Oliger and Shamim Ruff to Its Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors Reata Pharmaceuticals, Inc.April 15, 2021 GMT PLANO, Texas, April 15, 2021 (GLOBE NEWSWIRE) Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced the appointments of Christy J. Oliger and Shamim Ruff to its Board of Directors, effective April 15, 2021. “We are excited to welcome Ms. Ruff and Ms. Oliger to Reata’s board,” said Warren Huff, Reata’s Chief Executive Officer and President. “They join at a critical point in Reata’s development having just submitted our first New Drug Application for bardoxolone methyl (“bardoxolone”) for the treatment of chronic kidney disease caused by Alport syndrome. Both Ms. Ruff and Ms. Oliger bring a wealth of experience that will be invaluable

CleanSpark Purchases 22,680 Additional Bitcoin Miners and Anticipates 3 2 EH/s Capacity After Deployment

Press release content from PR Newswire. The AP news staff was not involved in its creation. CleanSpark Purchases 22,680 Additional Bitcoin Miners and Anticipates 3.2 EH/s Capacity After Deployment April 15, 2021 GMT CleanSpark, Inc. Logo (PRNewsfoto/CleanSpark, Inc.) SALT LAKE CITY, April 15, 2021 /PRNewswire/ CleanSpark, Inc. (Nasdaq: CLSK) (the “Company” or “CleanSpark”), a diversified software, services, and Bitcoin mining company, today announced that it has secured multiple contracts for mining equipment. The Company has now secured contracts for all of the equipment necessary for CleanSpark’s mining operation to increase its Bitcoin mining capacity to meet its stated objective of a total hash rate capacity of more than 1.1 EH/s by summer of 2021. Additionally, CleanSpark has now secured a total of 22,680 S19j Pro and S19 Pro Antminers for future delivery under annual contracts. The Company contracted directly with Bitmain Technologies Ltd. for 7,200 Sj19 Pro An

Bullous Pemphigoid Epidemiology Forecast Report 2018-2020 & 2021-2030

Press release content from Business Wire. The AP news staff was not involved in its creation. Bullous Pemphigoid Epidemiology Forecast Report 2018-2020 & 2021-2030 - ResearchAndMarkets.com April 15, 2021 GMT This ‘Bullous Pemphigoid-Epidemiology Forecast-2030’ report deliver an in-depth understanding of the Bullous Pemphigoid historical and forecasted epidemiology trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. ADVERTISEMENT Bullous Pemphigoid Overview Bullous Pemphigoid (BP) is an acquired autoimmune subepidermal bullous disease in which autoantibodies are directed against the skin’s basement membrane zone components. Mainly IgG (rarely IgA, IgM, and IgE) autoantibodies bind to components of the hemidesmosome adhesion complex, the BP230, and BP180 antigens.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.